Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study

Objectives Although uric acid lowering therapies, including xanthine oxidase (XO) inhibition, may reduce the absolute level of blood pressure (BP), the effect of XO inhibition on BP variability is largely unknown. The aim of the present analysis was to evaluate the impact of febuxostat, an XO inhibi...

Full description

Bibliographic Details
Main Authors: Yoshio Kobayashi, Atsushi Tanaka, Yuichi Saito, Daigaku Uchida, Koichi Node, Naoto Yokota, Hisako Yoshida, Yuji Koide, Kazuo Matsunaga, Chikara Ueyama
Format: Article
Language:English
Published: BMJ Publishing Group 2022-09-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002505.full